摘要
本文详细阐明新型冠状病毒肺炎的发病机理和导致重症患者死亡的原因,是新型冠状病毒诱发免疫应答,形成大量以免疫复合物和中性粒细胞为主要成分的微血栓,血栓栓塞肺泡血管,引起的急性进行性肺微循环障碍。在此基础上提出重症患者的中西医结合急救治疗策略。
This artical elucidate the pathogenesis and the reason causing the death of severe patients for Novel Coronavirus Pneumonia(COVID-19)in detail.The reason is the novel coronavirus(2019-nCoV)induced immune response then formed micro thrombus,which main component is a quantity of immune complex and neutrophil.Micro thrombus block alveolar vessel,finaly cause acutely progressive pulmonary microcirculatory disturbance.Finaly,putting forward the acute treatment strategy with integrated traditional Chinese and western medicine for severe patients based on it.
作者
曾升平
Sheng-Ping Zeng(the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu Sichuan,610075,China)
出处
《TMR经典中医研究》
2020年第2期36-45,共10页
Classical Chinese Medicine Research
